Echo Therapeutics (ECTE) is 'Disappointed' in Platinum's Proxy Contest
Tweet Send to a Friend
Echo Therapeutics, Inc. (Nasdaq: ECTE) commented on the recent proxy statement filings made with the Securities and Exchange Commission (SEC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE